Work

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension (P8-1.005)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000209016

Authors: Jiwon Oh, Jelena Drulovic, Michal Dufek, Hrvoje Budincevic, Mario Habek, Maresa Caunt, Malgorzata Sierzega, David Clayton, Ying-Fang Chen, Jack Ratchford, Alexandra Goodyear, Amit Bar-Or

Institutions: St. Michael's Hospital, St Michael’s Hospital, Univerzitetski Klinički Centar Srbije, St. Anne's University Hospital Brno, University Hospital Centre Zagreb, Genentech, Roche (Switzerland), University of Pennsylvania

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409235770

FWCI: 0.58

Cites:

Cited by: 1

Related to: 10